SENKRONİZE ÜÇLÜ PRİMER SERVİKS, ENDOMETRİYUM VE TUBA KANSERİ: OLGU SUNUMU

Year 2014, Volume: 17 Issue: 3, 0 - 0, 01.07.2014

Abdullah Boztosun Dinçer Sümer Hatice Özer Handan Aker Ali Yanık

Abstract

Senkron multipl orijinli jinekolojik kanser görülmesi oldukça nadirdir ve literatürde kısıtlı sayıda vaka yayımlanmıştr. Elli bir yaşında
servikal Papanicolaou test sonucu ‘atipik glandüler hücreler’ ve endometriyal biyopsi sonucu ‘endometrial adenokarsinom’
olan hastaya tip 3 total abdominal histerektomi, bilateral salpingooferektomi, infrakolik omentektomi, komplet pelvik-paraaortik
lenf nodu diseksiyonu ve appendektomi uygulandı. Nihai patoloji primer serviks, endometriyum ve tubal karsinom olarak izlendi.

Keywords

Senkron, Primer üçlü kanser

TRIPLE SYNCHRONOUS PRIMARY CERVICAL, ENDOMETRIAL AND FALLOPIAN CANCER: A CASE REPORT

Abstract

Occurrence of synchronous triple primary gynecological cancers is extremely rare ,only few cases has been reported. Fifty one
years old patient had ‘atypical glandular cells’ at cervical Papanicolaou test and ‘endometrial adenocarcinoma’ at endometrial
sampling and was performed Type 3 total abdominal hysterectomy, bilateral salpingooopherectomy, infracolic omentectomy,
complete pelvic-paraaortic lymphadenectomy and appendectomy. Final pathologies were concomitant primary cervical, endometrial
and fallopian cancer.

Keywords

Synchronous, Primary, triple carcinoma

References

• 1. Ree YS, Cho SH, Kim SR, Kim KT, Park MH. Synchronous primary endometrial and ovarian cancer with three diVerent histologic patterns: a case report. Int J Gynecol Cancer 2003. 13:678–682.
• 2. Eisner RF, Nieberg RK, Berek JS. Synchronous primary neoplasms of the female reproductive tract. Gynecol Oncol 1989. 33:335–339.
• 3. Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE. Simultaneously detected endometrial and ovarian carcinomas—a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol 2001. 83:355–362.
• 4. Phupong V. Triple synchronous primary cervical, endometrial and ovarian cancer with four diVerent histologic patterns Arch Gynecol Obstet 2007. 276:655–658.
• 5. Saglam A. Four synchronous female genital malignancies: the ovary, cervix, endometrium and fallopian tube Arch Gynecol Obstet 2008. 277:557–562.
• 6. Atasever et al Synchronous Primary Carcinoma in 5 Different Organs of a Female Genital Tract An Unusual Case and Review of the Literature International Journal of Gynecological Cancer & Volume 19, Number 4, May 2009.
• 7. Eifel P, Hendrickson M, Ross J, Ballon S, Martinez A, Kempson R. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer 1982.50:163–170.
• 8. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol 1985.16:28–34.
• 9. Ayhan A, Yalçin OT, Tuncer ZS, Gürgan T, Küçükali T Synchronous primary malignancies of the female genital tract Eur J Obstet Gynecol Reprod Biol. 1992 Jun 16;45(1):63-6.
• 10. WoodruV JD, Solomon D, Sullivant H. Multifocal diseases in the upper genital canal. Obstet Gynecol 1985. 65:695–698.
• 11. Eifel P, Hendrickson M, Ross J, et al. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer. 1982;50:163Y170.
• 12. Woodruff JD, Julian CG. Multiple malignancy in the upper genital tract. Am J Obstet Gynecol. 1993;43:305- 312.
• 13. Soliman PT, Slomovitz BM, Broaddus RR, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases [review]. Gynecol Oncol. 2004;94:456Y462.
• 14. Liao S, Shang J, Tian X, Fan X, Shi X, Pei S, Wang Q, Yu B. Up-regulation of melanin synthesis by the antidepressant fl uoxetine. Exp Dermatol. 2012 Aug;21(8):635-7.
• 15. Treeck O, Haldar C, Ortmann O. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines. Oncol Rep. 2006 Jan;15(1):231-5.
• 16. Watanabe M, Kobayashi Y, Takahashi N, Kiguchi K, Ishizuka B. Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line. J Obstet Gynaecol Res. 2008 Aug;34(4):567-73.